查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1708022

全球登革热检测市场：产业分析、规模、份额、成长、趋势和预测（2025-2032 年）

Dengue Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 240 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计 2025 年全球登革热检测市场规模将达到 5.835 亿美元，到 2032 年将达到 8.658 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.8%。

登革热检测市场包括用于检测疑似感染个体中是否有登革热病毒的诊断测试。这些测试有助于确定患者是否患有登革热，登革热是由蚊虫叮咬传播的登革热病毒引起的。由于热带和亚热带地区登革热发病率的增加、医疗保健意识的增强以及诊断技术的进步，市场正在稳步增长。市面上有各种检测方法，包括基于 ELISA 的检测、RT-PCR 检测和快速登革热检测，主要用于医院、诊断中心和公共卫生实验室。

登革热检测市场的成长主要是由于携带病毒的家猫在热带和亚热带地区流行，导致登革热发病率不断上升。全球气候变迁、都市化和人口流动导致登革热病例增加，因此快速且准确的诊断至关重要。对登革热早期发现和管理的需求日益增长，促使医疗机构采用先进的诊断技术。此外，政府控制登革热疫情和改善医疗保健基础设施的倡议，以及越来越多地采用照护现场诊断工具（POC）也是推动市场发展的主要因素。

儘管对登革热检测的需求不断增长，但仍有几个因素限制市场的成长。诊断测试的成本很高，尤其是在低收入国家，限制了先进测试技术的采用。此外，偏远和农村地区缺乏基础设施和训练有素的人力，阻碍了检测策略的有效实施。此外，由于检测方法不同导致的诊断准确性差异，以及检测可用性和品管问题，也为市场带来了挑战。此外，一些地区对早期诊断重要性的认识不足，导致检测延迟，进而影响整体市场的成长。

由于分子诊断技术（尤其是具有高灵敏度和特异性的 RT-PCR）的进步，登革热检测市场提供了巨大的成长机会。实验室和诊断中心自动化程度的不断提高为开发更有效率、更快捷的测试解决方案提供了机会。此外，人们对开发能够检测多种感染疾病（包括登革热）的多重诊断试剂套件的兴趣日益浓厚，这可能会推动市场扩张。南美洲、拉丁美洲和非洲等登革热常见地区的新兴市场为市场进入者提供了丰厚的机会。增加对公共卫生计划的投资和开发具有成本效益的测试方案可能会为市场成长提供进一步的机会。

本报告研究了全球登革热检测市场，并按产品类型、最终用户、区域趋势和参与市场的公司概况进行细分。

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 市场动态
  • COVID-19影响分析
  • 预测因子－相关性和影响力

第三章 增值洞察

第四章全球登革热检测市场展望

  • 主要亮点
  • 市场规模分析与预测
    • 2019-2024 年历史市场规模分析
    • 2025-2032年目前市场规模分析与预测
  • 全球登革热检测市场展望（依产品类型）
    • 2019 年至 2024 年按产品类型分類的历史市场规模分析
    • 2025 年至 2032 年按产品类型分類的当前市场规模分析与预测
    • 按产品类型进行市场吸引力分析
  • 全球登革热检测市场前景（按最终用户）
    • 2019 年至 2024 年最终用户市场规模历史分析
    • 2025 年至 2032 年按最终用户分類的当前市场规模分析和预测
    • 最终用户的市场吸引力分析

5. 全球登革热检测市场（按地区）展望

  • 2019 年至 2024 年各地区历史市场规模分析
  • 2025 年至 2032 年各地区目前市场规模分析与预测
    • 北美洲
    • 拉丁美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 中东和非洲
  • 按地区分析市场吸引力

6. 北美登革热检测市场展望

7. 欧洲登革热检测市场展望

8. 东亚登革热检测市场展望

9. 南亚和大洋洲登革热检测市场展望

10. 拉丁美洲登革热检测市场展望

11.中东和非洲登革热检测市场展望

第十二章竞争格局

  • 2025年市场占有率分析
  • 市场结构
  • 公司简介（详情－概述、财务状况、策略、最新发展）
    • Thermo Fisher Scientific Inc.
    • Abnova Corporation
    • Roche Molecular Systems Inc.
    • Abbott Laboratories
    • InBios International, Inc.
    • NovaTec Immundiagnostica GmbH
    • Euroimmun AG（Sub. PerkinElmer）
    • Quest Diagnostics
    • Certest Biotec SL
    • OriGene Technologies
    • Jiangsu BioPerfectus Technologies Co., Ltd
    • Vitrosens Biyoteknoloji A.
    • ACON Biotech（Hangzhou）Co., Ltd.
    • Biozek
    • Mankind Pharma Pvt Ltd
    • Sun Pharmaceutical Industries Ltd
    • 其他的

第十三章 附录

简介目录
Product Code: PMRREP22738

Persistence Market Research has recently released a comprehensive report on the global Dengue Testing Market, offering an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report provides a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Dengue Testing Market Size (2025E): US$ 583.5 Mn
  • Projected Market Value (2032F): US$ 865.8 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.8%

Dengue Testing Market - Report Scope:

The Dengue Testing Market includes diagnostic tests used to detect the presence of the dengue virus in individuals suspected of being infected. These tests help determine whether a patient has dengue fever, which is caused by the dengue virus transmitted through mosquito bites. With increasing incidences of dengue in tropical and subtropical regions, along with rising healthcare awareness and advancements in diagnostic technology, the market is experiencing steady growth. The market includes a variety of testing methods such as ELISA-based tests, RT-PCR tests, and dengue rapid tests, which are primarily used in hospitals, diagnostic centers, and public health laboratories.

Market Growth Drivers:

The growth of the Dengue Testing Market is primarily driven by the increasing prevalence of dengue fever in tropical and subtropical regions, where the Aedes mosquitoes that transmit the virus are common. Global climate change, urbanization, and population mobility contribute to the rising number of dengue cases, making rapid and accurate diagnostics crucial. The growing demand for early detection and management of dengue fever is prompting healthcare facilities to adopt advanced diagnostic technologies. Furthermore, government initiatives to control dengue outbreaks and improve healthcare infrastructure, coupled with the rising adoption of point-of-care (POC) diagnostic tools, are key factors driving the market.

Market Restraints:

Despite the growing demand for dengue testing, several factors are restraining market growth. The high cost of diagnostic tests, particularly in low-income countries, limits the widespread adoption of advanced testing technologies. Additionally, the lack of infrastructure and trained personnel in remote and rural areas hampers the effective implementation of testing strategies. The variability in diagnostic accuracy between different testing methods, as well as challenges related to test availability and quality control, also poses challenges for the market. Moreover, limited awareness about the importance of early diagnosis in certain regions contributes to delayed testing, thereby impacting overall market growth.

Market Opportunities:

The Dengue Testing Market presents significant growth opportunities, particularly with advancements in molecular diagnostic techniques like RT-PCR, which offer higher sensitivity and specificity. The growing trend towards automation in laboratories and diagnostic centers presents an opportunity for the development of more efficient and faster testing solutions. Additionally, there is a growing focus on the development of multiplex diagnostic kits capable of detecting multiple infectious diseases, including dengue, which could drive market expansion. Emerging markets in regions like South Asia, Latin America, and Africa, where dengue outbreaks are frequent, provide a lucrative opportunity for market players. Increased investment in public health initiatives and the development of cost-effective testing options will further open up opportunities for market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the global dengue testing market's growth?
  • Which regions and market segments are experiencing the highest demand for dengue testing?
  • How are innovations in diagnostic technologies influencing market dynamics?
  • Who are the key players in the dengue testing market, and what strategies are they adopting to stay competitive?
  • What are the emerging trends and future projections for the global dengue testing market?

Competitive Intelligence and Business Strategy:

Leading companies in the global dengue testing market, such as Abnova Corporation, Roche Molecular Systems Inc., Abbott Laboratories, InBios International, Inc., and others, are focusing on product innovation, strategic partnerships, and expanding their global presence. These companies are investing in research and development to improve the sensitivity and specificity of dengue tests. They are also exploring opportunities to expand their market reach through partnerships with public health organizations and diagnostic centers. Collaborating with governmental health agencies to provide affordable diagnostic solutions in endemic regions is becoming a key strategic focus to enhance market penetration.

Companies Covered in This Report:

  • Abnova Corporation
  • Roche Molecular Systems Inc.
  • Abbott Laboratories
  • InBios International, Inc.
  • NovaTec Immundiagnostica GmbH
  • Euroimmun AG (Sub. PerkinElmer)
  • Quest Diagnostics
  • Certest Biotec S.L.
  • OriGene Technologies

Dengue Testing Market Segmentation:

By Product Type:

  • ELISA-based Tests
  • RT-PCR based Tests
  • Dengue IgG/IgM Rapid Test
  • Others

By End-User:

  • Hospitals
  • Public Health Laboratories
  • Diagnostic Centers
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Dengue Testing Market Snapshot, 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. COVID-19 Impact Analysis
  • 2.4. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Value Chain Analysis
  • 3.2. Technology Adoption / Usage Analysis
  • 3.3. Diseases Epidemiology
  • 3.4. Key Market Players
  • 3.5. Regulatory Landscape
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Forces Analysis
  • 3.8. Consumer Behavior Analysis

4. Global Dengue Testing Market Outlook

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Mn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
  • 4.3. Global Dengue Testing Market Outlook: Product Type
    • 4.3.1. Historical Market Size (US$ Mn) Analysis, By Product Type, 2019-2024
    • 4.3.2. Current Market Size (US$ Mn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.3.2.1. ELISA-based Tests
      • 4.3.2.2. RT-PCR based Tests
      • 4.3.2.3. Dengue IgG/IgM Rapid Test
      • 4.3.2.4. Others
    • 4.3.3. Market Attractiveness Analysis: Technology
  • 4.4. Global Dengue Testing Market Outlook: End-User
    • 4.4.1. Historical Market Size (US$ Mn) Analysis, By End-User, 2019-2024
    • 4.4.2. Current Market Size (US$ Mn) Analysis and Forecast, By End-User, 2025-2032
      • 4.4.2.1. Hospitals
      • 4.4.2.2. Public Health Laboratory
      • 4.4.2.3. Diagnostic Centers
      • 4.4.2.4. Others
    • 4.4.3. Market Attractiveness Analysis: End-User

5. Global Dengue Testing Market Outlook Region

  • 5.1. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 5.2. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2025-2032
    • 5.2.1. North America
    • 5.2.2. Latin America
    • 5.2.3. Europe
    • 5.2.4. East Asia
    • 5.2.5. South Asia and Oceania
    • 5.2.6. Middle East & Africa
  • 5.3. Market Attractiveness Analysis: Region

6. North America Dengue Testing Market Outlook

  • 6.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 6.1.1. By Country
    • 6.1.2. By Product Type
    • 6.1.3. By End-User
  • 6.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 6.2.1. U.S.
    • 6.2.2. Canada
  • 6.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 6.3.1. ELISA-based Tests
    • 6.3.2. RT-PCR based Tests
    • 6.3.3. Dengue IgG/IgM Rapid Test
    • 6.3.4. Others
  • 6.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 6.4.1. Hospitals
    • 6.4.2. Public Health Laboratory
    • 6.4.3. Diagnostic Centers
    • 6.4.4. Others
  • 6.5. Market Attractiveness Analysis

7. Europe Dengue Testing Market Outlook

  • 7.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.1.1. By Country
    • 7.1.2. By Product Type
    • 7.1.3. By End-User
  • 7.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. U.K.
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Russia
    • 7.2.7. Rest of Europe
  • 7.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 7.3.1. ELISA-based Tests
    • 7.3.2. RT-PCR based Tests
    • 7.3.3. Dengue IgG/IgM Rapid Test
    • 7.3.4. Others
  • 7.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 7.4.1. Hospitals
    • 7.4.2. Public Health Laboratory
    • 7.4.3. Diagnostic Centers
    • 7.4.4. Others
  • 7.5. Market Attractiveness Analysis

8. East Asia Dengue Testing Market Outlook

  • 8.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.1.1. By Country
    • 8.1.2. By Product Type
    • 8.1.3. By End-User
  • 8.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 8.2.1. China
    • 8.2.2. Japan
    • 8.2.3. South Korea
  • 8.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 8.3.1. ELISA-based Tests
    • 8.3.2. RT-PCR based Tests
    • 8.3.3. Dengue IgG/IgM Rapid Test
    • 8.3.4. Others
  • 8.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 8.4.1. Hospitals
    • 8.4.2. Public Health Laboratory
    • 8.4.3. Diagnostic Centers
    • 8.4.4. Others
  • 8.5. Market Attractiveness Analysis

9. South Asia & Oceania Dengue Testing Market Outlook

  • 9.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.1.1. By Country
    • 9.1.2. By Product Type
    • 9.1.3. By End-User
  • 9.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 9.2.1. India
    • 9.2.2. Indonesia
    • 9.2.3. Thailand
    • 9.2.4. Singapore
    • 9.2.5. ANZ
    • 9.2.6. Rest of South Asia & Oceania
  • 9.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 9.3.1. ELISA-based Tests
    • 9.3.2. RT-PCR based Tests
    • 9.3.3. Dengue IgG/IgM Rapid Test
    • 9.3.4. Others
  • 9.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 9.4.1. Hospitals
    • 9.4.2. Public Health Laboratory
    • 9.4.3. Diagnostic Centers
    • 9.4.4. Others
  • 9.5. Market Attractiveness Analysis

10. Latin America Dengue Testing Market Outlook

  • 10.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.1.1. By Country
    • 10.1.2. By Product Type
    • 10.1.3. By End-User
  • 10.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 10.2.1. Brazil
    • 10.2.2. Mexico
    • 10.2.3. Rest of Latin America
  • 10.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 10.3.1. ELISA-based Tests
    • 10.3.2. RT-PCR based Tests
    • 10.3.3. Dengue IgG/IgM Rapid Test
    • 10.3.4. Others
  • 10.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 10.4.1. Hospitals
    • 10.4.2. Public Health Laboratory
    • 10.4.3. Diagnostic Centers
    • 10.4.4. Others
  • 10.5. Market Attractiveness Analysis

11. Middle East & Africa Dengue Testing Market Outlook

  • 11.1. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.1.1. By Country
    • 11.1.2. By Product Type
    • 11.1.3. By End-User
  • 11.2. Current Market Size (US$ Mn) Analysis and Forecast by Country, 2025-2032
    • 11.2.1. GCC Countries
    • 11.2.2. Egypt
    • 11.2.3. South Africa
    • 11.2.4. Northern Africa
    • 11.2.5. Rest of Middle East & Africa
  • 11.3. Current Market Size (US$ Mn) Analysis and Forecast by Product Type, 2025-2032
    • 11.3.1. ELISA-based Tests
    • 11.3.2. RT-PCR based Tests
    • 11.3.3. Dengue IgG/IgM Rapid Test
    • 11.3.4. Others
  • 11.4. Current Market Size (US$ Mn) Analysis and Forecast, by End-User, 2025-2032
    • 11.4.1. Hospitals
    • 11.4.2. Public Health Laboratory
    • 11.4.3. Diagnostic Centers
    • 11.4.4. Others
  • 11.5. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping by Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Thermo Fisher Scientific Inc.
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Sources
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Abnova Corporation
    • 12.3.3. Roche Molecular Systems Inc.
    • 12.3.4. Abbott Laboratories
    • 12.3.5. InBios International, Inc.
    • 12.3.6. NovaTec Immundiagnostica GmbH
    • 12.3.7. Euroimmun AG (Sub. PerkinElmer)
    • 12.3.8. Quest Diagnostics
    • 12.3.9. Certest Biotec S.L.
    • 12.3.10. OriGene Technologies
    • 12.3.11. Jiangsu BioPerfectus Technologies Co., Ltd
    • 12.3.12. Vitrosens Biyoteknoloji A.
    • 12.3.13. ACON Biotech (Hangzhou) Co., Ltd.
    • 12.3.14. Biozek
    • 12.3.15. Mankind Pharma Pvt Ltd
    • 12.3.16. Sun Pharmaceutical Industries Ltd
    • 12.3.17. Others

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations